Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02435147 · ClinicalTrials.gov registry record
Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index
A clinical trial of Osteoporosis and Bone Fracture, sponsored by HealthEast Care System.
- Completed
- Registry status
- 86
- Enrollment target
- 1
- Study location
NCT02435147 is a study of Osteoporosis and Bone Fracture that has completed, run by HealthEast Care System. The registered enrollment target is 86 participants, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02435147, a study of Osteoporosis and Bone Fracture, has completed, sponsored by HealthEast Care System.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to validate the long-term benefit of denosumab for osteoporosis treatment in a real-world clinical practice setting. We hypothesize that continued therapy (36+months) with denosumab will increase both trabecular bone score (TBS) and femur strength index (FSI) and reduce fracture and other bone health risks among post-menopausal women with osteoporosis.
Conditions Studied
Interventions
- DRUG denosumab
Study Locations (1)
Minnesota
- HealthEast Care System - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02435147
The ClinicalTrials.gov registry entry for NCT02435147 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (94% lower). The listed sponsor is HealthEast Care System, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which denosumab is the first listed.
NCT02435147 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02435147 about?
NCT02435147 is a clinical study titled "Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index". The purpose of this study is to validate the long-term benefit of denosumab for osteoporosis treatment in a real-world clinical practice setting. We hypothesize that continued therapy (36+months) with denosumab will increase both trabecular bone score (TBS) and femur strength index (FSI) and reduce ...
What is the current status of trial NCT02435147?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2015-04. Estimated completion is 2016-06.
What conditions does trial NCT02435147 study?
This clinical trial studies the following conditions: Osteoporosis, Bone Fracture.
What interventions are being tested in trial NCT02435147?
The interventions under investigation include: denosumab (DRUG).
Who is sponsoring clinical trial NCT02435147?
This trial is sponsored by HealthEast Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02435147 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
RECRUITING · NA
-
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
RECRUITING
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Preserving Geriatric Muscle With an Osteoporosis Medication
RECRUITING · Phase 4
-
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
RECRUITING · NA
-
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.